Skip to content
Homepage
Author:
Syncromune
Posted Date:
June 16, 2026
Syncromune Presents Multi-Modal Efficacy Assessment Framework at Inaugural Gustave Roussy Intratumoral Immunotherapy Symposium
Syncromune
June 16, 2026
Syncromune®, Inc. Presents Innovative SYNC-T™ Combination Immunotherapy Approach at Major European Interventional Oncology Conference
Syncromune
May 7, 2026
